BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells.

FEBS Lett

Hemocentro, Departamento de Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, P.O. Box 6198, 13083-970 Campinas, SP, Brazil.

Published: January 2003

In the present study we used K562 cells to demonstrate that insulin receptor substrate 1 (IRS-1) is expressed and constitutively phosphorylated in BCR-ABL(+) cells. We observed association between BCR-ABL/IRS-1, IRS-1/phosphoinositide 3'-kinase (PI3-kinase), and IRS-1/Grb2 in the K562 cell line. Our findings demonstrate that imatinib treatment resulted in marked attenuation of BCR-ABL/IRS-1 association and of IRS-1-stimulated PI3-kinase activity in K562 cells. We concluded that the IRS-1 protein is involved in the signalling pathway of the BCR-ABL tyrosine kinase.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-5793(02)03845-0DOI Listing

Publication Analysis

Top Keywords

k562 cells
12
bcr-abl binds
4
irs-1
4
binds irs-1
4
irs-1 irs-1
4
irs-1 phosphorylation
4
phosphorylation inhibited
4
inhibited imatinib
4
k562
4
imatinib k562
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!